Los Angeles Allergist

Los Angeles Allergist

Alan Khadavi, MD, APC
  • Home
  • Meet Dr. Khadavi
  • Conditions We Treat
  • Your First Visit
  • Insurance Accepted
  • Allergy and Asthma Info
    • Asthma Info
    • Allergic Rhinitis
    • Allergic Triggers
  • Blog
  • Media
  • Contact Us

9001 Wilshire Blvd. Suite 204
Beverly Hills, CA 90211
Phone: 310-282-8822

15450 Ventura Blvd. Suite 102
Sherman Oaks, CA 91403
Phone: 818-528-7776

January 16, 2021 by Alan Khadavi

Singulair psychiatric side effects; a large study

Much has been written about the potential of Singulair psychiatric side effects, with conflicting results. Singulair (montelukast) is a leukotriene-modifying agent approved for the treatment of  asthma, exercise induced bronchospasm, perennial allergic rhinitis and seasonal allergic rhinitis. It is approved for children as young as 6 months of age depending on the condition.

In 2008/09, the FDA updated the “Warnings and Precautions” of Singulair to include agitation, aggressive behavior or hostility, anxiousness, depression, disorientation, dream abnormalities, hallucinations, insomnia, irritability, restlessness, suicidal thinking and behavior and tremor.

Since the labeling changes, there have conflicting results regarding the risks of Singulair psychiatric side effects.  A recent study published in The Journal of Allergy and Clinical Immunology: In Practice, January 2021, title “Risk of Psychiatric Adverse Events Among Montelukast Users” sought to determine whether there was an association between the two. Specifically they tried to determine whether there was an increased risk of depressive disorders, self-harm and completed suicides compared to those on Singulair vs. inhaled corticosteroid use.

The study did not find any associations between Singulair use and inpatient depressive disorder or self-harm, compared with inhaled steroid use, either overall or across subgroups of age, sex or calendar time.

The data analyzed took over a 15 year period and involved 457,377 patients, exposed to either Singulair or an inhaled steroid for asthma. Psychiatric co-morbodity was common amongst patients, most psychiatric events that did occur were in patients having a past psychiatric history.

As with all new medications, patients and doctors should closely monitor for any potential side effects. There were psychiatric side effects in both treatment groups (Singulair vs. Inhaled Steroids), but the study did not show any significant increased risk compared to one another.

A limitation of the study only compared Singulair vs. inhaled steroids, it did not compare them to untreated patients.

As always speak to your doctor about any concerns you have with medications, overall the risk was very low of singulair psychiatric side effects.

FDA advises against Singulair going OTC

FDA requires Boxed Warning about serious mental health side effects for asthma and allergy drug montelukast (Singulair); advises restricting use for allergic rhinitis

Update January 10, 2024

A study called “The Risk of Neuropsychiatric Adverse Events with Use of Leukotriene Receptor Antagonists in Patients with Asthma: Analysis of Korea’s National Health Insurance Sharing Service Database” concluded that there was an increased risk of hallucinations and attention problems in those taking montelukast.  Physicians should ask patients about hallucinations and attention problems and alert patients when it is prescribed. In this study, those were the only neuropsychiatric events that showed statistical significance of being observed with montelukast.

Filed Under: Blog, Headlines

alan-khadavi
Dr. Alan Khadavi
Allergy & Asthma Specialist

Latest Posts

November 17, 2026

Low Dose Naltrexone for MCAS: Benefits, Risks, and Evidence

LDN for MCAS

November 13, 2026

Cardamom Allergy: Symptoms, Diagnosis, and What to Avoid

cardamom allergy

October 28, 2026

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

October 26, 2026

Which Biologic Works Best for Nasal Polyps?

best biologic for nasal polyps

October 19, 2026

Xolair vs. Omlyclo: Cost, Effectiveness, Insurance & Switching

Xolair vs Omlyclo: Cost, Effectiveness, Insurance & Switching

October 8, 2026

Tapioca Allergy: Can Cassava Cause an Allergic Reaction?

tapioca allergy

October 8, 2026

Rhapsido for Symptomatic Dermographism: An Allergist Explains the New FDA-Approved Treatment

Rhapsido for symptomatic dermographism

October 6, 2026

Most Effective Treatments for Severe Atopic Dermatitis: New Rankings

`most-effective-treatments-severe-atopic-dermatitis

October 6, 2026

Should Airlines Be Required to Carry Epinephrine? An Allergist Explains

airline epinephrine requirement

October 2, 2026

Ketotifen for MCAS: Uses, Benefits, Side Effects, and U.S. Availability

ketotifen for MCAS

Read More Posts...

Follow Us…

© 2026 Allergy Los Angeles. All Rights Reserved · Log in · Return to top of page